Jackson Square Capital LLC grew its stake in Danaher Corporation (NYSE:DHR – Free Report) by 213.0% in the 3rd quarter, Holdings Channel.com reports. The firm owned 28,981 shares of the conglomerate’s stock after purchasing an additional 19,721 shares during the period. Danaher comprises approximately 1.0% of Jackson Square Capital LLC’s holdings, making the stock its 28th largest position. Jackson Square Capital LLC’s holdings in Danaher were worth $6,421,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Veery Capital LLC raised its position in Danaher by 3.1% in the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after purchasing an additional 48 shares during the period. Studio Investment Management LLC boosted its position in shares of Danaher by 3.3% during the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after buying an additional 51 shares during the period. JDH Wealth Management LLC boosted its position in shares of Danaher by 4.5% during the first quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after buying an additional 55 shares during the period. OLD Second National Bank of Aurora grew its stake in shares of Danaher by 0.5% in the first quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock valued at $2,297,000 after buying an additional 57 shares in the last quarter. Finally, Adelphi Trust Co grew its stake in shares of Danaher by 2.5% in the third quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate’s stock valued at $524,000 after buying an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
DHR has been the topic of several research analyst reports. Royal Bank Of Canada boosted their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Guggenheim raised their target price on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Barclays boosted their price target on shares of Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Sunday. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $235.41.
Read Our Latest Stock Analysis on DHR
Danaher Stock Down 1.8%
Shares of NYSE DHR traded down $4.12 during mid-day trading on Monday, hitting $224.91. The company had a trading volume of 1,511,911 shares, compared to its average volume of 4,440,547. The company has a market capitalization of $158.11 billion, a PE ratio of 39.94, a price-to-earnings-growth ratio of 2.88 and a beta of 0.76. The business’s 50-day simple moving average is $214.04 and its 200 day simple moving average is $196.06. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 EPS. On average, analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s payout ratio is currently 28.42%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.
The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.
Read More
- Five stocks we like better than Danaher
- Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?
- Insider Buying Is Rising at These 3 Regional Banks, But the Details Matter
- Illinois Tool Works Faces Headwinds—2 Alternatives Stand Out
- Luxury’s Middle Market Is Cracking—These 3 Stocks Could Win
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
